In this evidence-based case report we studied the clinical question: Does intranasal corticosteroid (INCS) monotherapy reduce time to recovery in adults with acute noncomplicated rhinosinusitis? The search yielded 490 papers, of which only two were relevant and had a high validity regarding our clinical question.
Get full access to this article
View all access options for this article.
References
1.
WilliamsonIGRumsbyKBengeSAntibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007; 298:2487–96.
2.
MeltzerEOBachertCStaudingerH.Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. J Allergy Clin Immunol2005; 116:1289–95.
3.
AshworthMCharltonJBallardKVariations in antibiotic prescribing and consultation rates for acute respiratory infection in UK general practices 1995–2000. Br J Gen Pract2005; 55:603–8.
4.
KuyvenhovenMvan EssenGSchellevisFManagement of upper respiratory tract infections in Dutch general practice; antibiotic prescribing rates and incidences in 1987 and 2001. Fam Pract2006; 23:175–9.
5.
GoetzelRZHawkinsKOzminkowskiRJThe health and productivity cost burden of the “top 10” physical and mental health conditions affecting six large U.S. employers in 1999. J Occup Environ Med2003; 45:5–14.
6.
MeltzerEOHamilosDLHadleyJARhinosinusitis: establishing definitions for clinical research and patient care.J Allergy Clin Immunol2004; 114(Suppl):155–212.
7.
YoungJDe SutterAMerensteinDAntibiotics for adults with clinically diagnosed acute rhinosinusitis: a meta-analysis of individual patient data. Lancet2008; 371:908–14.
8.
RosenfeldRMAndesDBhattacharyyaNClinical practice guideline: adult sinusitis.Otolaryngol Head Neck Surg2007; 137(Suppl):S1–31.
9.
GoossensHFerechMVander SticheleROutpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet2005; 365:579–87.
10.
KlevensRMMorrisonMANadleJInvasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA2007; 298:1763–71.
11.
KuninCM.Resistance to antimicrobial drugs—a worldwide calamity. Ann Intern Med1993; 118:557–61.
12.
BaroodyFMMuchaSMdeTineoMNasal challenge with allergen leads to maxillary sinus inflammation. J Allergy Clin Immunol2008; 121:1126–32.
13.
KirtsreesakulVNaclerioRM.Role of allergy in rhinosinusitis. Curr Opin Allergy Clin Immunol2004; 4:17–23.
14.
HicknerJMBartlettJGBesserREPrinciples of appropriate antibiotic use for acute rhinosinusitis in adults: background. Ann Intern Med2001; 134:498–505.
15.
NielsenLPDahlR.Comparison of intranasal corticosteroids and antihistamines in allergic rhinitis: a review of randomized, controlled trials. Am J Respir Med2003; 2:55–65.
16.
WeinerJMAbramsonMJPuyRM.Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials. BMJ1998; 317:1624–9.
17.
BruniFMDe LucaGVenturoliVIntranasal corticosteroids and adrenal suppression. Neuroimmunomodulation2009; 16:353–62.
18.
ZittMKosoglouTHubbellJ.Mometasone furoate nasal spray: a review of safety and systemic effects. Drug Saf2007; 30:317–26.
19.
FokkensWLundVMullolJ.EP3OS 2007: European position paper on rhinosinusitis and nasal polyps 2007. A summary for otorhinolaryngologists. Rhinology2007; 45:97–101.
